These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15206060)

  • 61. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
    Alfirevic A; Pirmohamed M
    Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacogenetics of antiretroviral therapy.
    Barreiro P; Fernández-Montero JV; de Mendoza C; Labarga P; Soriano V
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1119-30. PubMed ID: 24941049
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
    Scharplatz M; Puhan M; Steurer J; Bachmann LM
    Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Uncertainties of routine HLA B*5701 testing in black African HIV cohorts in the UK.
    Sadiq ST; Pakianathan M
    Sex Transm Infect; 2007 Jun; 83(3):181-2. PubMed ID: 17098765
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmacogenomics of antimicrobial agents.
    Aung AK; Haas DW; Hulgan T; Phillips EJ
    Pharmacogenomics; 2014; 15(15):1903-30. PubMed ID: 25495412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections.
    Chaisson RE; Gebo K; Flexner C; Gallant JE; Lucas GM; Bartlett JG
    HIV Clin Trials; 2002; 3(4):333-49. PubMed ID: 12187508
    [No Abstract]   [Full Text] [Related]  

  • 67. Time (again) for a randomized trial of pharmacogenetics of antiretroviral therapy.
    Telenti A
    Pharmacogenomics; 2009 Apr; 10(4):515-6. PubMed ID: 19374508
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 69. HIV pharmacogenetics in clinical practice: recent achievements and future challenges.
    Tozzi V; Libertone R; Liuzzi G
    Curr HIV Res; 2008 Nov; 6(6):544-54. PubMed ID: 18991620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacogenomics of CYP3A: considerations for HIV treatment.
    Lakhman SS; Ma Q; Morse GD
    Pharmacogenomics; 2009 Aug; 10(8):1323-39. PubMed ID: 19663676
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.
    Arab-Alameddine M; Décosterd LA; Buclin T; Telenti A; Csajka C
    Expert Opin Drug Metab Toxicol; 2011; 7(5):609-22. PubMed ID: 21500966
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Pharmacogenetics].
    Merk HF
    Hautarzt; 2010 Aug; 61(8):650-3. PubMed ID: 20644905
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of pharmacogenetics on HIV therapy.
    Mahungu TW; Johnson MA; Owen A; Back DJ
    Int J STD AIDS; 2009 Mar; 20(3):145-51. PubMed ID: 19255258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. "Personalized medicine: elusive dream or imminent reality?": A commentary.
    Roses A
    Clin Pharmacol Ther; 2007 Jun; 81(6):801-5. PubMed ID: 17505494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Pharmacogenetic contribution to individualized treatment. Severe adverse effects can be avoided].
    Eliasson E
    Lakartidningen; 2008 May 28-Jun 3; 105(22):1644-5. PubMed ID: 18590003
    [No Abstract]   [Full Text] [Related]  

  • 76. Precision medicine for HIV: where are we?
    Cusato J; Allegra S; Nicolò A; Calcagno A; D'Avolio A
    Pharmacogenomics; 2018 Jan; 19(2):145-165. PubMed ID: 29202676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Antiretroviral treatment associated life-threatening adverse events].
    Moreno-Cuerda VJ; Morales-Conejo M; Rubio R
    Med Clin (Barc); 2006 May; 126(19):744-9. PubMed ID: 16759591
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Delayed drug sensitivity].
    del Valle Loarte P; Cervero Jiménez M; Joya Seijo MD; Jusdado Ruiz-Capillas JJ; Torres Perea R
    Rev Clin Esp; 2003 Dec; 203(12):617-8. PubMed ID: 14622520
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacogenetics of anti-HIV drugs.
    Telenti A; Zanger UM
    Annu Rev Pharmacol Toxicol; 2008; 48():227-56. PubMed ID: 17883329
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Individualization of antiretroviral therapy--pharmacogenomic aspect.
    Dalal B; Shankarkumar A; Ghosh K
    Indian J Med Res; 2015 Dec; 142(6):663-74. PubMed ID: 26831415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.